Celgene gets options to Prothena's tau, TDP-43 antibodies

Prothena Corp. plc (NASDAQ:PRTA) added $7.45 (22%) to $41.30 in after-hours trading after granting Celgene Corp. (NASDAQ:CELG) exclusive options to neurodegenerative

Read the full 219 word article

User Sign In